59142C40
SUPELCOSIL™ LC-ABZ (5 µm) HPLC Columns
L × I.D. 25 cm × 4 mm, HPLC Column
Synonym(s):
Analytical LC-ABZ Chromatography Column
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
UNSPSC Code:
41115700
eCl@ss:
32110501
NACRES:
SB.52
L × i.d.:
25 cm × 4 mm
Particle size:
5 μm
Matrix active group:
HILIC Amide, amide, alkyl phase
Pore size:
120 Å
Matrix:
silica gel, spherical particle platform, fully porous particle
Product Name
SUPELCOSIL™ LC-ABZ HPLC Column, 5 μm particle size, L × I.D. 25 cm × 4 mm
material
stainless steel column
Quality Segment
agency
suitable for USP L60
product line
SUPELCOSIL™
feature
endcapped
manufacturer/tradename
SUPELCOSIL™
packaging
1 ea of
extent of labeling
12.0% carbon loading
parameter
≤70 °C temp. limit, 400 bar pressure (5801 psi)
technique(s)
HPLC: suitable
L × I.D.
25 cm × 4 mm
surface area
170 m2/g
surface coverage
surface coverage 3.4 μmol/m2
matrix
silica gel, spherical particle platform, fully porous particle
matrix active group
HILIC Amide, amide, alkyl phase
particle size
5 μm
pore size
120 Å
pH range
2-7.5
application(s)
food and beverages
separation technique
reversed phase
General description
SUPELCOSIL LC-ABZ phase has a unique deactivation technology which provides excellent reversed-phase performance for basic compounds, as well as those that are acidic, polar neutral, and non-polar. Silanol suppressing practices such as using competing amines, operating at high ionic strength, and adjusting mobile phases to pH extremes are typically not required to obtain good peak shape on the LC-ABZ phase.
Application
- Determination of active substances in binary mixture antiparasitic veterinary formulations by HPLC: This study showcases the use of the SUPELCOSIL™ LC-ABZ HPLC column for the precise determination of active compounds in veterinary medicine. This application is crucial in ensuring the effectiveness and safety of veterinary drugs. The study highlights the column′s capability to handle complex mixtures in pharmaceutical formulations, demonstrating its effectiveness in both academic research settings and in quality control for pharmaceutical applications (Kulik et al., 2011).
Features and Benefits
• For acids, bases, zwitterions
• Increased polar retention relative to standard reversed-phases
• Unique selectivity
• Silanol deactivation
• Peak shape, efficiency, and retention are comparable to C8 phases for non-polar analytes
• Increased polar retention relative to standard reversed-phases
• Unique selectivity
• Silanol deactivation
• Peak shape, efficiency, and retention are comparable to C8 phases for non-polar analytes
Legal Information
SUPELCOSIL is a trademark of Sigma-Aldrich Co. LLC
Still not finding the right product?
Explore all of our products under SUPELCOSIL™ LC-ABZ HPLC Column
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.